The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | 4,048 | 195,000 | SH | SOLE | 195,000 | 0 | 0 | ||
| ACHILLION PHARMACEUTICALS INC | COM | 00448Q201 | 1,012 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
| AGIOS PHARMACEUTICALS | COM | 00847X104 | 10,025 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
| AMAG PHARMACEUTICALS INC | COM | 00163U106 | 8,400 | 420,000 | SH | SOLE | 420,000 | 0 | 0 | ||
| AMARIN CORP PLC | SPONSORED ADR | 023111206 | 26,032 | 1,600,000 | SH | SOLE | 1,600,000 | 0 | 0 | ||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 6,667 | 375,000 | SH | SOLE | 375,000 | 0 | 0 | ||
| ARQULE INC | COM | 04269E107 | 3,113 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
| ARDELYX INC | COM | 039697107 | 2,827 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
| AUDENTES THERAPEUTICS INC | COM | 05070R104 | 8,907 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
| AXOGEN INC | COM | 05463X106 | 47,905 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | ||
| BIOFRONTERA AG | SPONSORED ADR | 09075G105 | 1,073 | 79,007 | SH | SOLE | 79,007 | 0 | 0 | ||
| BIOLINERX LTD | SPONSORED ADR | 09071M106 | 267 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| BLUEPRINT MEDICINES | COM | 09627Y109 | 23,418 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| CARA THERAPEUTICS INC | COM | 140755109 | 3,113 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
| CELLECTIS SA | SPONSORED ADS | 15117K103 | 3,104 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
| CHIMERIX INC | COM | 16934W106 | 4,609 | 1,185,000 | SH | SOLE | 1,185,000 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 5,280 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
| CLEMENTIA PHARMACEUTICAL INC | COM | 185575107 | 1,660 | 148,832 | SH | SOLE | 148,832 | 0 | 0 | ||
| CODEXIS INC | COM | 192005106 | 30,012 | 1,750,000 | SH | SOLE | 1,750,000 | 0 | 0 | ||
| CORIUM INTERNATIONAL INC | COM | 21887L107 | 5,230 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM | 12648L601 | 3,348 | 1,550,000 | SH | SOLE | 1,550,000 | 0 | 0 | ||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 7,735 | 698,100 | SH | SOLE | 698,100 | 0 | 0 | ||
| DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 16,262 | 420,000 | SH | SOLE | 420,000 | 0 | 0 | ||
| DERMIRA INC | COM | 24983L104 | 1,061 | 97,400 | SH | SOLE | 97,400 | 0 | 0 | ||
| EPIZYME INC | COM | 29428V104 | 2,120 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| FENNEC PHARMACEUTICALS INC | COM | 31447P100 | 7,995 | 975,000 | SH | SOLE | 975,000 | 0 | 0 | ||
| FIBROGEN INC | COM | 31572Q808 | 12,150 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| FOAMIX LTD | SHS | M46135105 | 521 | 91,000 | SH | SOLE | 91,000 | 0 | 0 | ||
| IMPRIMIS PHARMACEUTICALS | COM NEW | 45323A201 | 4,503 | 1,620,000 | SH | SOLE | 1,620,000 | 0 | 0 | ||
| INFINITY PHARMACEUTICALS INC | COM | 45665G303 | 745 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 3,656 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
| LOXO ONCOLOGY | COM | 548862101 | 29,895 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
| MAGENTA THERAPEUTICS INC | COM | 55910K108 | 8,707 | 725,000 | SH | SOLE | 725,000 | 0 | 0 | ||
| MIRAGEN THERAPEUTICS INC | COM | 60463E103 | 7,788 | 1,395,700 | SH | SOLE | 1,395,700 | 0 | 0 | ||
| OCULAR THERAPEUTIX INC | COM | 67576A100 | 5,504 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
| POLARITYTE INC | COM | 731094108 | 14,611 | 765,000 | SH | SOLE | 765,000 | 0 | 0 | ||
| PROTALIX BIOTHERAPEUTICS INC | COM | 74365A101 | 1,817 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | ||
| PTC THERAPEUTICS INC | COM | 69366J200 | 8,460 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
| SANGAMO BIOSCIENCES INC | COM | 800677106 | 8,305 | 490,000 | SH | SOLE | 490,000 | 0 | 0 | ||
| STRONGBRIDGE BIOPHARMA PLC | COM | G85347105 | 8,390 | 1,730,000 | SH | SOLE | 1,730,000 | 0 | 0 | ||
| TG THERAPEUTICS INC | COM | 88322Q108 | 1,960 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| TRICIDA INC | COM | 89610F101 | 1,558 | 51,000 | SH | SOLE | 51,000 | 0 | 0 | ||
| ULTRAGENYX PHARMACEUTICALS INC | COM | 90400D108 | 6,107 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
| VIKING THERAPEUTICS INC | COM | 92686J106 | 14,371 | 825,000 | SH | SOLE | 825,000 | 0 | 0 | ||
| XENCOR INC | COM | 98401F105 | 6,140 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 7,014 | 465,200 | SH | SOLE | 465,200 | 0 | 0 | ||
| XOMA CORP DEL | COM NEW | 98419J206 | 5,622 | 320,000 | SH | SOLE | 320,000 | 0 | 0 | ||